De Novo device
Sepsis ImmunoScore
Prenosis, Inc. · Software Device To Aid In The Prediction Or Diagnosis Of Sepsis (SAK, Class II) · First FDA decision Apr 2, 2024, newest Apr 2, 2024Sepsis
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
De Novo pathway
Device trials
0
Naming "Sepsis ImmunoScore"
MAUDE reports
0
Brand "Sepsis ImmunoScore", since 2015
PubMed studies
4
Mentioning "Sepsis ImmunoScore"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Sepsis ImmunoScore
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Sepsis ImmunoScoreNew device typeDe Novo
DEN230036 · Decided Apr 2, 2024 · 333 days after receipt
Device type: Software Device To Aid In The Prediction Or Diagnosis Of Sepsis (SAK) · Hospital Medicine & Nursing
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Sepsis ImmunoScore", any status and sponsor, newest update first.
No registered device study names "Sepsis ImmunoScore".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Sepsis ImmunoScore", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code SAK
35 reports: 35 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Sepsis ImmunoScore"[tiab]. The summary above synthesizes these.
- FDA-Authorized AI/ML Tool for Sepsis Prediction: Development and Validation.
Bhargava A, López-Espina C, Schmalz L, et al. · NEJM AI · 2024
- The Sepsis ImmunoScore Predicts Sepsis, Mortality, and Deterioration Better than Clinical Scores and Widely Available Biomarkers.
Watson GL, Updike LC, López-Espina CG, et al. · Diagnostics (Basel) · 2026
- Recent advances in early screening and diagnosis of sepsis: a narrative review.
Zhou XL, Hu XB, Shu LY, et al. · Front Cell Infect Microbiol · 2026Review
- Artificial intelligence for sepsis management in the emergency department.
de Vries FMC, Wiersinga WJ, Schinkel M · BMC Infect Dis · 2026Review
Other devices of this type
Also filed under product code SAK.
- Bayesian Health Sepsis Flagging DeviceBayesian Health, Inc. · 510(k) 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.